prepared in collaboration with the WHO Collaborating Centre for International Drug Monitoring, Uppsala, Sweden
No. 1, 2000
The aim of this Newsletter is to disseminate information on the safety and efficacy of pharmaceutical products, based on information received from our network of "drug information officers" and other sources such as specialized bulletins and journals, as well as partners in WHO. The Newsletter is now being prepared in collaboration with the WHO Collaborating Centre for International Drug Monitoring who are providing information on adverse drug reactions. The information is produced in the form of resumes in English, full texts of which may be obtained on request from: Quality Assurance and Safety: Medicines, EDM-HTP, World Health Organization, 1211 Geneva 27, Switzerland
E-mail address: QSM@who.int
Fax: +41 22 791 4730
Extensive information on medicines may be obtained from our Internet site: http://www.who.int/'medicines
Further information on adverse reactions may be obtained from the WHO Collaborating Centre for International Drug Monitoring, Stora Target 3, S-753 20 Uppsala, Sweden
Tel: 46-18-65.60.60
Fax: 46-18-65.60.80
E-mail: sten.olsson@who-umc.org
Internet:http://www.who-umc.org
Loading...
